143 related articles for article (PubMed ID: 29676828)
1. β-arrestin1-medieated inhibition of FOXO3a contributes to prostate cancer cell growth in vitro and in vivo.
Kong Z; Deng T; Zhang M; Zhao Z; Liu Y; Luo L; Cai C; Wu W; Duan X
Cancer Sci; 2018 Jun; 109(6):1834-1842. PubMed ID: 29676828
[TBL] [Abstract][Full Text] [Related]
2. β-arrestin1 promotes epithelial-mesenchymal transition via modulating GSK-3β/β-catenin pathway in prostate cancer cells.
Duan X; Zhang T; Kong Z; Mai X; Lan C; Chen D; Liu Y; Zeng Z; Cai C; Deng T; Wu W; Zeng G
Biochem Biophys Res Commun; 2016 Oct; 479(2):204-210. PubMed ID: 27620488
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
Chen H; Luo Q; Li H
Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
[TBL] [Abstract][Full Text] [Related]
4. MiR-96 expression in prostate cancer and its effect on the target gene regulation.
Bao YH; Wang Y; Liu Y; Wang S; Wu B
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4548-4556. PubMed ID: 29131261
[TBL] [Abstract][Full Text] [Related]
5. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
Zhou R; Lu Z; Liu K; Guo J; Liu J; Zhou Y; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
[TBL] [Abstract][Full Text] [Related]
6. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
[TBL] [Abstract][Full Text] [Related]
7. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
[TBL] [Abstract][Full Text] [Related]
8. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer.
Das TP; Suman S; Alatassi H; Ankem MK; Damodaran C
Cell Death Dis; 2016 Feb; 7(2):e2111. PubMed ID: 26913603
[TBL] [Abstract][Full Text] [Related]
10. miR-1307 promotes the proliferation of prostate cancer by targeting FOXO3A.
Qiu X; Dou Y
Biomed Pharmacother; 2017 Apr; 88():430-435. PubMed ID: 28122308
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
Dey P; Ström A; Gustafsson JÅ
Oncogene; 2014 Aug; 33(33):4213-25. PubMed ID: 24077289
[TBL] [Abstract][Full Text] [Related]
12. FOXO3a and Its Regulators in Prostate Cancer.
Habrowska-Górczyńska DE; Kozieł MJ; Kowalska K; Piastowska-Ciesielska AW
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830408
[TBL] [Abstract][Full Text] [Related]
13. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
[TBL] [Abstract][Full Text] [Related]
14. SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway.
Li R; Quan Y; Xia W
Exp Cell Res; 2018 Mar; 364(2):143-151. PubMed ID: 29421536
[TBL] [Abstract][Full Text] [Related]
15. FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.
Imada K; Shiota M; Kuroiwa K; Sugimoto M; Abe T; Kohashi K; Yokomizo A; Eto M; Naito S; Oda Y
Prostate; 2017 Feb; 77(2):145-153. PubMed ID: 27699813
[TBL] [Abstract][Full Text] [Related]
16. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
18. [FOXO3a signaling pathway in prostate cancer: Progress in studies].
Tao Y; Li LL; Liu SH; Hong M
Zhonghua Nan Ke Xue; 2020 Aug; 26(8):745-750. PubMed ID: 33377739
[TBL] [Abstract][Full Text] [Related]
19. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
20. Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A/BIM signaling in a double-transgenic mouse model.
Wang S; Wang N; Yu B; Cao M; Wang Y; Guo Y; Zhang Y; Zhang P; Yu X; Wang S; Zeng L; Liang B; Li X; Wu Y
Oncogene; 2019 Sep; 38(36):6338-6353. PubMed ID: 31312023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
